Page last updated: 2024-09-05

razaxaban and pd 0348292

razaxaban has been researched along with pd 0348292 in 1 studies

Compound Research Comparison

Studies (razaxaban)	Trials (razaxaban)	Recent Studies (post-2010) (razaxaban)	Studies (pd 0348292)	Trials (pd 0348292)	Recent Studies (post-2010) (pd 0348292)
20	0	2	9	2	2

Protein Interaction Comparison

Protein	Taxonomy	razaxaban (IC50)	pd 0348292 (IC50)
Coagulation factor X	Homo sapiens (human)		0.0004

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cheney, DL; Knabb, RM; Pinto, DJ; Smallheer, JM; Wexler, RR	1

Reviews

1 review(s) available for razaxaban and pd 0348292

Article	Year
Factor Xa inhibitors: next-generation antithrombotic agents. Journal of medicinal chemistry, 2010, Sep-09, Volume: 53, Issue:17 Topics: Administration, Oral; Animals; Anticoagulants; Biological Availability; Clinical Trials as Topic; Drug Design; Drug Evaluation, Preclinical; Factor Xa Inhibitors; Hemostasis; Humans; Models, Molecular; Protein Conformation; Structure-Activity Relationship; Thrombosis	2010

Article

Year

Factor Xa inhibitors: next-generation antithrombotic agents.

Journal of medicinal chemistry, 2010, Sep-09, Volume: 53, Issue:17

Topics: Administration, Oral; Animals; Anticoagulants; Biological Availability; Clinical Trials as Topic; Drug Design; Drug Evaluation, Preclinical; Factor Xa Inhibitors; Hemostasis; Humans; Models, Molecular; Protein Conformation; Structure-Activity Relationship; Thrombosis

2010